Grunvald E, Shah R, Hernaez R, Chandar AK, Pickett-Blakely O et al (2022) AGA clinical practice guideline on Pharmacological interventions for adults with obesity
The diagrams in a , e and h were created using BioRender
Close physician monitoring, regular laboratory work, and growth assessment are essential if therapy is considered
When the primary complaint is poor sleep quality, specifically difficulty falling or staying asleep, and energy or muscle are secondary concerns, the first-line recommendation is often Epithalon rather than either of the more commonly discussed therapies
ROS and RNS may trigger programmed cell death, e.g., apoptosis [29], necessary for tissue remodeling during the development and normal tissue turnover [30], proliferation, differentiation, maturation of neural stem cells, dendritic processes, and synaptic plasticity [31,32,33]
A quality provider will approach this conversation without judgment and help you weigh potential risks and benefits within the context of your treatment plan
